The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
The impact of aromatic ring count on compound developability – are too many aromatic rings a liability in drug design?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420 · cited 1×
“Although the increased lipophilicity that results from increased aromatic ring count can be offset by the inclusion of heteroatom functionality (often in the ring itself), this will increase the polar surface area and might result in exceeding the recognized limits for permeability/absorption [8, 9 ].”
BackgroundDrug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403 · cited 3×
“Catalyzed by Lipinski’s seminal ‘rule of five’ for absorption and permeability [1], there is now a substantial body of literature describing property space occupied by orally bioavailable smallmolecule drugs [ 2 ,3].”
BackgroundInfluentialThe Characterization of Two Specific Drug Binding Sites on Human Serum Albumin
SUDLOW, G., BIRKETT, D. J., & WADE, D. N. (1975) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10691-3 · Cited by 1,725
Physiochemical drug properties associated with in vivo toxicological outcomes
Hughes, J. D., Blagg, J., Price, D. A., Bailey, S., DeCrescenzo, G. A., Devraj, R. V., Ellsworth, E., Fobian, Y. M., Gibbs, M. E., Gilles, R. W., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.071 · Cited by 946
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans
Palm, K., Stenberg, P., Luthman, K., & Artursson1, P. (1997) · Pharmaceutical Research · doi:10.1023/a:1012188625088 · Cited by 756
A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs
Wenlock, M. C., Austin, R. P., Barton, P., Davis, A. M., & Leeson, P. D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021053p · Cited by 546
Methods and Principles in Medicinal Chemistry
(2008) · Methods and principles in medicinal chemistry · doi:10.1002/series6138 · Cited by 514
Cited by
The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
Roughley, S. D., & Jordan, A. M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200187y · Cited by 2,725
Rings in Drugs: Miniperspective
Taylor, R. D., MacCoss, M., & Lawson, A. D. G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4017625 · Cited by 2,543
Quantifying the chemical beauty of drugs
Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,242
The use of spirocyclic scaffolds in drug discovery
Zheng, Y., Tice, C. M., & Singh, S. B. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.06.081 · Cited by 1,036
The Structure and Function of DNA G-Quadruplexes
Spiegel, J., Adhikari, S., & Balasubramanian, S. (2020) · Trends in Chemistry · doi:10.1016/j.trechm.2019.07.002 · Cited by 920
“optimal for a small molecule with good pharmacokinetic properties [34,35].”
BackgroundLipophilicity in drug discovery
Waring, M. J. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441003605098 · Cited by 873
Liu, Y., Han, S.-J., Liu, W.-B., & Stoltz, B. M. (2015) · Accounts of Chemical Research · doi:10.1021/ar5004658 · Cited by 825
Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design
Subbaiah, M. A. M., & Meanwell, N. A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01215 · Cited by 710
Meanwell, N. A. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200211v · Cited by 620
A systematic analysis of atomic protein–ligand interactions in the PDB
Ferreira de Freitas, R., & Schapira, M. (2017) · MedChemComm · doi:10.1039/c7md00381a · Cited by 610
Understanding Cell Penetration of Cyclic Peptides
Dougherty, P. G., Sahni, A., & Pei, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00008 · Cited by 570
Put a ring on it: application of small aliphatic rings in medicinal chemistry
Bauer, M. R., Di Fruscia, P., Lucas, S. C. C., Michaelides, I. N., Nelson, J. E., Storer, R. I., & Whitehurst, B. C. (2021) · RSC Medicinal Chemistry · doi:10.1039/d0md00370k · Cited by 479
Macrocycles In New Drug Discovery
Mallinson, J., & Collins, I. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.93 · Cited by 468
Stepan, A. F., Subramanyam, C., Efremov, I. V., Dutra, J. K., O’Sullivan, T. J., DiRico, K. J., McDonald, W. S., Won, A., Dorff, P. H., Nolan, C. E., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300094u · Cited by 468
Ritchie, T. J., Macdonald, S. J. F., Young, R. J., & Pickett, S. D. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.11.014 · Cited by 442
Self-citationShultz, M. D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00686 · Cited by 434
50 years of oral lipid-based formulations: provenance, progress and future perspectives
Feeney, O. M., Crum, M. F., McEvoy, C. L., Trevaskis, N. L., Williams, H. D., Pouton, C. W., Charman, W. N., Bergström, C. A. S., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.007 · Cited by 426
Opportunities for Tapping into Three-Dimensional Chemical Space through a Quaternary Carbon
Talele, T. T. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00829 · Cited by 424
Lead‐Oriented Synthesis: A New Opportunity for Synthetic Chemistry
Nadin, A., Hattotuwagama, C., & Churcher, I. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201105840 · Cited by 390
What Do Medicinal Chemists Actually Make? A 50-Year Retrospective
Walters, W. P., Green, J., Weiss, J. R., & Murcko, M. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200504p · Cited by 387
Classification of scaffold-hopping approaches
Sun, H., Tawa, G., & Wallqvist, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.024 · Cited by 375
Two‐ and Three‐dimensional Rings in Drugs
Aldeghi, M., Malhotra, S., Selwood, D. L., & Chan, A. W. E. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12260 · Cited by 372
Molecular obesity, potency and other addictions in drug discovery
Hann, M. M. (2011) · MedChemComm · doi:10.1039/c1md00017a · Cited by 363
Stereoselective synthesis and applications of spirocyclic oxindoles
Boddy, A. J., & Bull, J. A. (2021) · Organic Chemistry Frontiers · doi:10.1039/d0qo01085e · Cited by 362
The Blood–Brain Barrier (BBB) Score
Gupta, M., Lee, H. J., Barden, C. J., & Weaver, D. F. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01220 · Cited by 332
Structure-based drug design with equivariant diffusion models
Schneuing, A., Harris, C., Du, Y., Didi, K., Jamasb, A., Igashov, I., Du, W., Gomes, C., Blundell, T. L., Lio, P., et al. (2024) · Nature Computational Science · doi:10.1038/s43588-024-00737-x · Cited by 316
Open-Air Alkylation Reactions in Photoredox-Catalyzed DNA-Encoded Library Synthesis
Phelan, J. P., Lang, S. B., Sim, J., Berritt, S., Peat, A. J., Billings, K., Fan, L., & Molander, G. A. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b00669 · Cited by 314
Young, R. J., Green, D. V. S., Luscombe, C. N., & Hill, A. P. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.06.001 · Cited by 311
Going further than Lipinski's rule in drug design
Walters, W. P. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.648612 · Cited by 306
Cooper, T. W. J., Campbell, I. B., & Macdonald, S. J. F. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201002238 · Cited by 299
Self-citationThe utilization of spirocyclic scaffolds in novel drug discovery
Zheng, Y.-J., & Tice, C. M. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1195367 · Cited by 299
Bellotti, P., & Glorius, F. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c08206 · Cited by 294
Synthesis of Saturated N-Heterocycles
Vo, C.-V. T., & Bode, J. W. (2014) · The Journal of Organic Chemistry · doi:10.1021/jo5001252 · Cited by 292
Ursu, O., Rayan, A., Goldblum, A., & Oprea, T. I. (2011) · WIREs Computational Molecular Science · doi:10.1002/wcms.52 · Cited by 276
Route to three-dimensional fragments using diversity-oriented synthesis
Hung, A. W., Ramek, A., Wang, Y., Kaya, T., Wilson, J. A., Clemons, P. A., & Young, D. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015271108 · Cited by 268
Lagorce, D., Douguet, D., Miteva, M. A., & Villoutreix, B. O. (2017) · Scientific Reports · doi:10.1038/srep46277 · Cited by 266
Three-dimensional saturated C(sp3)-rich bioisosteres for benzene
Tsien, J., Hu, C., Merchant, R. R., & Qin, T. (2024) · Nature Reviews Chemistry · doi:10.1038/s41570-024-00623-0 · Cited by 263
Targeted and multifunctional arene ruthenium chemotherapeutics
Smith, G. S., & Therrien, B. (2011) · Dalton Transactions · doi:10.1039/c1dt11007a · Cited by 262
Locke, G. M., Bernhard, S. S. R., & Senge, M. O. (2019) · Chemistry – A European Journal · doi:10.1002/chem.201804225 · Cited by 261
Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity
Hill, A. P., & Young, R. J. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.05.016 · Cited by 258
Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs
Bergström, C. A. S., Holm, R., Jørgensen, S. A., Andersson, S. B. E., Artursson, P., Beato, S., Borde, A., Box, K., Brewster, M., Dressman, J., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.10.015 · Cited by 257
Labbé, C. M., Laconde, G., Kuenemann, M. A., Villoutreix, B. O., & Sperandio, O. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.003 · Cited by 104
Cheng, P. T. W., Kaltenbach, R. F., Zhang, H., Shi, J., Tao, S., Li, J., Kennedy, L. J., Walker, S. J., Shi, Y., Wang, Y., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01256 · Cited by 61
Which three-dimensional characteristics make efficient inhibitors of protein–protein interactions?
Kuenemann, M. A., Bourbon, L. M. L., Labbé, C. M., Villoutreix, B. O., & Sperandio, O. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500487q · Cited by 42
A Homogeneous HTRF Assay for the Identification of Inhibitors of the TWEAK-Fn14 Protein Interaction
Benicchi, T., Iozzi, S., Svahn, A., Axelsson, H., Mori, E., Bernocco, S., Cappelli, F., Caramelli, C., Fanti, P., Genesio, E., et al. (2012) · SLAS Discovery · doi:10.1177/1087057112447873 · Cited by 12
“4 nM reported elsewhere.(3,16,31) We deliberately chose to work with very low protein concentrations in order to increase the chances of finding small-molecule inhibitors.”
Background
Metadata
- Authors
- Ritchie, T. J., & Macdonald, S. J. F.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 14
- Issue
- 21-22
- Pages
- 1011-1020
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2169303530
- Cited by
- 901
- References
- 22
- FWCI
- 26.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.